Company Filing History:
Years Active: 2013-2015
Title: Innovations of Ping-Heng Tan in Analgesic Methods and Gene Silencing
Introduction
Ping-Heng Tan is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the fields of pharmacology and genetic engineering. With a total of four patents to his name, his work focuses on innovative methods for pain relief and gene knockdown techniques.
Latest Patents
One of his latest patents is an analgesic method that includes an oligonucleotide, specifically a double strand RNA comprising 18 to 70 base pairs. This analgesic medication is designed to deliver the oligonucleotide into cells using a pharmaceutical acceptable vehicle. The dosage of the oligonucleotide in the analgesic ranges from 50 to 200 µg/kg per time, with the vehicle selected from polyethyleneimine, lipofectamine, and iFect. Another significant patent involves a microRNA-based short hairpin RNA for gene knockdown of the NR1 subunit of the N-methyl-D-aspartate receptor. This invention relates to gene silencing through a single strand RNA fragment that includes complementary fragments and a connecting fragment, which is crucial for the genetic expression of the NR1 subunit.
Career Highlights
Ping-Heng Tan is affiliated with I-Shou University, where he continues to engage in research and development in his areas of expertise. His work has implications for both therapeutic applications and advancements in genetic research.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Ping-Heng Tan's innovative patents in analgesic methods and gene silencing demonstrate his significant contributions to science and medicine. His work continues to pave the way for advancements in pharmacological treatments and genetic engineering.